Fulgent Genetics (FLGT) Short Interest Ratio & Short Volume $22.17 +0.14 (+0.64%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$22.18 +0.01 (+0.05%) As of 08/29/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Fulgent Genetics Short Interest DataFulgent Genetics (FLGT) has a short interest of 2.09 million shares, representing 10.60% of the float (the number of shares available for trading by the public). This marks a 12.37% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.0, indicating that it would take 7.0 days of the average trading volume of 270,210 shares to cover all short positions.Current Short Interest2,090,000 sharesPrevious Short Interest1,860,000 sharesChange Vs. Previous Month+12.37%Dollar Volume Sold Short$35.91 millionShort Interest Ratio7.0 Days to CoverLast Record DateJuly 31, 2025Outstanding Shares30,610,000 sharesFloat Size19,720,000 sharesShort Percent of Float10.60%Today's Trading Volume348,546 sharesAverage Trading Volume270,210 sharesToday's Volume Vs. Average129% Short Selling Fulgent Genetics? Sign up to receive the latest short interest report for Fulgent Genetics and its competitors with MarketBeat's FREE newsletter. Email Address Get Report View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartFLGT Short Interest Over TimeFLGT Days to Cover Over TimeFLGT Percentage of Float Shorted Over Time Fulgent Genetics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 7/31/20252,090,000 shares $35.91 million +12.4%10.6%7 $17.18 7/15/20251,860,000 shares $33.61 million -3.6%9.5%6.3 $18.07 6/30/20251,930,000 shares $38.37 million +17.0%9.8%6.2 $19.88 6/15/20251,650,000 shares $34.14 million +2.5%8.4%4.8 $20.69 5/31/20251,610,000 shares $33.18 million -9.0%8.2%3.5 $20.61 5/15/20251,770,000 shares $35.47 million +2.3%9.0%3.6 $20.04 4/30/20251,730,000 shares $30.02 million -1.7%8.8%3.6 $17.35 4/15/20251,760,000 shares $33.58 million +15.8%8.9%4 $19.08 3/31/20251,520,000 shares $25.69 million -7.9%7.7%3.5 $16.90 3/15/20251,650,000 shares $28.45 million +19.6%8.3%4 $17.24 Get the Latest News and Ratings for FLGT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter. 2/28/20251,380,000 shares $21.32 million +6.2%7.0%4.5 $15.45 2/15/20251,300,000 shares $21.97 million +23.8%6.5%5.1 $16.90 1/31/20251,050,000 shares $17.47 million -1.9%5.2%3.9 $16.64 1/15/20251,070,000 shares $18.09 million +10.2%5.3%4.2 $16.91 12/31/2024970,600 shares $17.93 million +18.2%4.9%4.1 $18.47 12/15/2024821,300 shares $16.08 million +9.7%4.1%3.7 $19.58 11/30/2024748,900 shares $13.70 million +29.3%3.8%3.7 $18.30 11/15/2024579,100 shares $10.02 million -10.3%2.9%3.2 $17.31 10/31/2024645,600 shares $13.85 million -4.5%3.3%4.3 $21.45 10/15/2024676,100 shares $13.70 million +5.6%3.4%4.6 $20.26 9/30/2024640,100 shares $13.91 million -11.5%3.2%3.8 $21.73 9/15/2024723,200 shares $16.16 million -1.3%3.7%4.1 $22.35 8/31/2024732,800 shares $16.53 million +4.8%3.7%4.1 $22.56 8/15/2024699,300 shares $16.44 million +0.8%3.6%3.9 $23.51 7/31/2024693,500 shares $16.60 million -11.5%3.5%3.8 $23.93 7/15/2024784,000 shares $16.67 million +0.2%4.1%4.4 $21.26 6/30/2024782,100 shares $15.34 million -0.2%4.1%4.8 $19.62 6/15/2024783,400 shares $14.96 million +8.7%4.1%4.9 $19.09 5/31/2024720,900 shares $14.89 million +2.4%3.7%4.3 $20.65 5/15/2024704,000 shares $15.89 million +3.2%3.7%3.4 $22.57 4/30/2024682,400 shares $13.89 million +9.1%3.5%3.1 $20.35 4/15/2024625,400 shares $12.98 million +3.5%3.1%2.9 $20.75 3/31/2024604,000 shares $13.11 million -1.2%3.0%2.9 $21.70 3/15/2024611,200 shares $13.50 million +22.6%3.2%2.9 $22.09 2/29/2024498,400 shares $11.24 million -3.6%2.6%2.2 $22.56 2/15/2024517,200 shares $13.28 million +10.1%2.7%2.7 $25.68 1/31/2024469,900 shares $11.55 million -7.5%2.5%2.5 $24.59 1/15/2024508,200 shares $14.21 million -7.9%2.7%2.4 $27.97 12/31/2023551,900 shares $15.96 million -15.0%2.9%2.5 $28.91 12/15/2023649,400 shares $18.30 million +4.7%3.4%2.8 $28.18Washington prepares for war (Ad)While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.Click here now to watch the urgent wartime exposé 11/30/2023620,400 shares $17.11 million -33.4%3.2%2.8 $27.58 11/15/2023931,700 shares $25.68 million +3.1%4.9%4 $27.56 10/31/2023903,600 shares $21.63 million +5.6%4.7%3.7 $23.94 10/15/2023855,900 shares $21.31 million +4.1%4.5%3.6 $24.90 9/30/2023821,900 shares $21.98 million +49.5%4.3%3.7 $26.74 9/15/2023549,800 shares $16.31 million -8.0%2.9%2.6 $29.67 8/31/2023597,900 shares $19.59 million +9.2%3.2%2.8 $32.76 8/15/2023547,400 shares $18.65 million -10.7%2.9%2.6 $34.07 7/31/2023613,100 shares $23.81 million -8.7%3.2%2.9 $38.83 7/15/2023671,800 shares $26.04 million +6.8%3.5%3.3 $38.76 6/30/2023629,100 shares $23.30 million -5.8%3.3%3.1 $37.03 6/15/2023667,600 shares $25.51 million -10.8%3.5%3.2 $38.21 5/31/2023748,700 shares $29.78 million -7.5%3.9%3.2 $39.77 5/15/2023809,500 shares $29.51 million +7.3%4.1%3.5 $36.46 4/30/2023754,300 shares $22.30 million +1.1%3.8%3.4 $29.57 4/15/2023745,800 shares $22.99 million -12.3%3.8%3.5 $30.83 3/31/2023850,000 shares $26.54 million -26.1%4.6%3.7 $31.22 3/15/20231,150,000 shares $36.78 million +26.6%6.2%4.8 $31.98 2/28/2023908,500 shares $29.79 million +5.9%4.9%3.8 $32.79 2/15/2023857,800 shares $29.16 million -4.4%4.6%3.7 $33.99 1/31/2023896,900 shares $30.30 million -23.3%4.8%3.3 $33.78 1/15/20231,170,000 shares $38.18 million +14.7%6.3%4.3 $32.63 12/30/20221,020,000 shares $30.38 million -14.3%5.5%3.7 $29.78 12/15/20221,190,000 shares $38.60 million +4.4%6.4%4.3 $32.44 11/30/20221,140,000 shares $41.35 million -1.7%6.0%4.1 $36.27 11/15/20221,160,000 shares $42.94 million -4.9%6.1%4 $37.02 10/31/20221,220,000 shares $48.35 million -4.7%5.9%4 $39.63 10/15/20221,280,000 shares $46.58 million -2.3%6.2%4.2 $36.39 9/30/20221,310,000 shares $49.94 million -3.0%6.3%4.2 $38.12 9/15/20221,350,000 shares $55.61 million -2.9%6.5%4.3 $41.19 8/31/20221,390,000 shares $60.42 million No Change6.7%4.4 $43.47 8/15/20221,390,000 shares $74.03 million -8.0%6.7%4.3 $53.26 7/31/20221,510,000 shares $90.22 million +0.7%7.3%4.4 $59.75 7/15/20221,500,000 shares $87.59 million +3.5%7.2%4.4 $58.39 6/30/20221,450,000 shares $79.07 million -5.2%7.0%4.1 $54.53 6/15/20221,530,000 shares $76.21 million -10.5%7.4%4.2 $49.81 5/31/20221,710,000 shares $93.21 million -0.6%8.2%4.5 $54.51 5/15/20221,720,000 shares $93.65 million +1.8%8.3%4.2 $54.45 4/30/20221,690,000 shares $92.75 million -3.4%8.0%4.2 $54.88 4/15/20221,750,000 shares $98.23 million +15.1%8.3%4 $56.13 3/31/20221,520,000 shares $94.86 million +0.7%N/A3.4 $62.41 3/15/20221,510,000 shares $84.94 million -7.4%7.2%3 $56.25 2/28/20221,630,000 shares $101.55 million -3.6%7.8%3.1 $62.30 2/15/20221,690,000 shares $112.37 million -15.1%8.2%3.2 $66.49 1/31/20221,990,000 shares $127.10 million -7.9%9.6%3.7 $63.87 1/15/20222,160,000 shares $172.71 million +17.4%N/A4.2 $79.96 12/31/20211,840,000 shares $185.09 million -11.5%8.9%3.8 $100.59 12/15/20212,080,000 shares $186.83 million -17.5%10.6%4.4 $89.82 11/30/20212,520,000 shares $235.67 million -4.9%12.9%5.5 $93.52 11/15/20212,650,000 shares $247.62 million -4.3%13.6%5.9 $93.44Washington prepares for war (Ad)While the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.Click here now to watch the urgent wartime exposé 10/29/20212,770,000 shares $229.69 million -6.7%14.4%5.8 $82.92 10/15/20212,970,000 shares $231.72 million No Change15.4%5.4 $78.02 9/30/20212,970,000 shares $267.15 million -10.3%15.4%4.9 $89.95 9/15/20213,310,000 shares $287.18 million -4.1%17.2%4.9 $86.76 8/31/20213,450,000 shares $314.78 million -10.4%18.1%4.9 $91.24 8/13/20213,850,000 shares $362.71 million -14.3%20.2%5.1 $94.21 7/30/20214,490,000 shares $414.20 million -14.3%24.0%5.7 $92.25 7/15/20215,240,000 shares $401.54 million -6.4%28.0%6.2 $76.63 6/30/20215,600,000 shares $516.49 million -2.4%29.9%6.5 $92.23 6/15/20215,740,000 shares $415.12 million +1.2%30.7%6 $72.32 5/28/20215,670,000 shares $419.98 million -3.4%30.3%5.1 $74.07 5/14/20215,870,000 shares $395.93 million -2.7%N/A4.1 $67.45 4/30/20216,030,000 shares $479.93 million -1.3%N/A3.7 $79.59 4/15/20216,110,000 shares $543.48 million +5.9%N/A3.4 $88.95 3/31/20215,770,000 shares $532.80 million +26.0%34.6%2.9 $92.34 3/15/20214,580,000 shares $437.85 million +15.7%27.5%2.1 $95.60 2/26/20213,960,000 shares $406.89 million +37.0%28.5%1.8 $102.75 2/12/20212,890,000 shares $494.13 million -30.9%20.8%1.4 $170.98 1/29/20214,180,000 shares $386.61 million +1.0%30.1%2 $92.49 1/15/20214,140,000 shares $285.95 million +5.6%29.8%2.3 $69.07 12/31/20203,920,000 shares $198.86 million +22.1%28.2%2.4 $50.73 12/15/20203,210,000 shares $143.71 million -12.3%23.1%2.5 $44.77 11/30/20203,660,000 shares $148.71 million +20.8%27.3%3 $40.63 11/15/20203,030,000 shares $129.68 million +45.0%23.7%2.6 $42.80 10/30/20202,090,000 shares $71.46 million +16.8%16.5%2.1 $34.19 10/15/20201,790,000 shares $68.32 million -6.8%15.5%1.8 $38.17 9/30/20201,920,000 shares $76.88 million +23.9%16.6%2 $40.04 9/15/20201,550,000 shares $46.95 million +31.4%13.5%1.7 $30.29 FLGT Short Interest - Frequently Asked Questions What is Fulgent Genetics' current short interest? Short interest is the volume of Fulgent Genetics shares that have been sold short but have not yet been covered or closed out. As of July 31st, traders have sold 2,090,000 shares of FLGT short. 10.60% of Fulgent Genetics' shares are currently sold short. Learn More on Fulgent Genetics' current short interest. What is a good short interest ratio for Fulgent Genetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FLGT shares currently have a short interest ratio of 7.0. Learn More on Fulgent Genetics's short interest ratio. Which institutional investors are shorting Fulgent Genetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fulgent Genetics: Group One Trading LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Fulgent Genetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 10.60% of Fulgent Genetics' floating shares are currently sold short. Is Fulgent Genetics' short interest increasing or decreasing? Fulgent Genetics saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 2,090,000 shares, an increase of 12.4% from the previous total of 1,860,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Fulgent Genetics' float size? Fulgent Genetics currently has issued a total of 30,610,000 shares. Some of Fulgent Genetics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fulgent Genetics currently has a public float of 19,720,000 shares. How does Fulgent Genetics' short interest compare to its competitors? 10.60% of Fulgent Genetics' shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Fulgent Genetics: Veracyte, Inc. (7.69%), Celcuity, Inc. (9.43%), Addus HomeCare Corporation (3.73%), LifeStance Health Group, Inc. (5.12%), Progyny, Inc. (9.89%), PACS Group, Inc. (6.32%), Viridian Therapeutics, Inc. (14.53%), Aveanna Healthcare Holdings Inc. (4.86%), Teladoc Health, Inc. (13.67%), AdaptHealth Corp. (11.46%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks. What does it mean to sell short Fulgent Genetics stock? Short selling FLGT is an investing strategy that aims to generate trading profit from Fulgent Genetics as its price is falling. FLGT shares are trading up $0.14 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fulgent Genetics? A short squeeze for Fulgent Genetics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FLGT, which in turn drives the price of the stock up even further. How often is Fulgent Genetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FLGT, twice per month. The most recent reporting period available is July, 31 2025. More Short Interest Resources from MarketBeat Related Companies Veracyte Short Squeeze Celcuity Short Squeeze Addus HomeCare Short Squeeze LifeStance Health Group Short Squeeze Progyny Short Squeeze PACS Group Short Squeeze Viridian Therapeutics Short Squeeze Aveanna Healthcare Short Squeeze Teladoc Health Short Squeeze AdaptHealth Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FLGT) was last updated on 9/1/2025 by MarketBeat.com Staff From Our PartnersRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredOne tiny company just cracked Google’s $19B problemAn MIT lab recently cracked a code scientists had been chasing for decades… Turning a “miracle metal” from ...True Market Insiders | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredA Major Economic Change Is Happening NowLouis Navellier is one of Wall Street’s most respected money managers — overseeing more than $7 billion and ea...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…A new set of 7 AI stocks are DOMINATING the market. Here’s why one financial guru says they could be the mo...The Oxford Club | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: Meta, Apple and NASA rush to invest in new "E.I." techBig Tech and even NASA are racing to back a breakthrough known as “E.I. Tech,” set to launch September 1st. Ex...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
